The expression levels of JUN, SFN, HSPB1, and CD47 in cancer cells and the expression levels of KLRB1, CD48, GZMK, and LY6E in CD8+ T cells were consistent with the scRNA-seq results (Fig. 8c, d). Here, JUN is linked to cancer.